Sensory Medical raises $1.4m for Relaxis restless legs treatment

Sensory Medical announces a $1.4 million tranche in a funding round for its Relaxis device to relieve symptoms of restless legs syndrome.

Sensory Medical shook a leg on a 2nd tranche of funding since receiving FDA clearance last spring for its device to relieve symptoms of restless legs syndrome, reporting $1.4 million in fresh funding on the heels of a $1 million tranche in June.

Sensory Medical

News Well, Funding Roundup, Neuromodulation/Neurostimulation, Restless Legs Syndrome

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1Dx4ocv